LMAT Stock: Price, Earnings History and SEC Filings
LeMaitre Vascular, Inc. (LMAT) last traded at $80.94, down 5.08% on the latest session and down 2.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.74 against an analyst estimate of $0.81, a miss of 8.6%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
LMAT earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $0.74 | $0.81 | -8.64% |
| Mar 2026 | May 5, 2026 | $0.68 | $0.66 | +3.03% |
| Dec 2025 | Feb 25, 2026 | $0.68 | $0.67 | +1.49% |
| Sep 2025 | Nov 6, 2025 | $0.62 | $0.57 | +8.77% |
LMAT beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How LMAT reacts to earnings
Across its last 8 earnings releases, LMAT moved 11.2% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-04 | After close | -25.32% |
| 2026-05-05 | After close | -1.59% |
| 2026-02-25 | After close | +24.41% |
| 2025-11-06 | After close | +1.43% |
| 2025-08-05 | After close | +8.91% |
| 2025-05-01 | After close | -12.79% |
| 2025-02-27 | After close | -8.07% |
| 2024-10-31 | After close | +7.34% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
LMAT financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $250M | $58M | – | 23.1% | $2.52 |
| 2024 | $220M | $44M | – | 20.0% | $1.93 |
| 2023 | $193M | $30M | – | 15.6% | $1.34 |
| 2022 | $162M | $21M | – | 12.8% | $0.93 |
| 2021 | $154M | $27M | – | 17.4% | $1.25 |
| 2020 | $129M | $21M | – | 16.4% | $1.04 |
| 2019 | $117M | $18M | – | 15.3% | $0.88 |
| 2018 | $106M | $23M | – | 21.7% | $1.13 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for LMAT
- 8-K · Oct 15, 2026Officer or director change
- 10-Q · Aug 5, 2026
- 8-K · Aug 4, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 5, 2026Shareholder vote
- 10-Q · May 6, 2026
- 8-K · May 5, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 14, 2026
- 8-K · Apr 14, 2026Officer or director change, Other events
- 10-K · Feb 26, 2026
- 8-K · Feb 25, 2026Results of operations, Financial statements and exhibits
Insider filing activity
LMAT insiders filed 10 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
LMAT news
- 3 cash-heavy stocks walking a fine lineOct 22, 2026 · finance.yahoo.com
About LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. (LMAT) is a US-listed public company on Nasdaq. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. Its fiscal year ends in December.